Baystate Wealth Management LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,067 filers reported holding BAXTER INTL INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Baystate Wealth Management LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$11,325
-47.6%
300
-36.7%
0.00%
-50.0%
Q2 2023$21,621
-64.3%
474
-68.3%
0.00%
-60.0%
Q1 2023$60,637
+79685.5%
1,4940.0%0.01%
-28.6%
Q4 2022$76
-99.9%
1,4940.0%0.01%
-12.5%
Q3 2022$80,000
-16.7%
1,4940.0%0.01%
-11.1%
Q2 2022$96,000
-17.2%
1,494
+0.3%
0.01%
-10.0%
Q1 2022$116,000
-10.1%
1,490
-0.5%
0.01%
-16.7%
Q4 2021$129,000
+8.4%
1,497
+0.9%
0.01%0.0%
Q3 2021$119,0000.0%1,4830.0%0.01%0.0%
Q2 2021$119,000
-4.8%
1,483
+0.1%
0.01%
-7.7%
Q1 2021$125,000
+0.8%
1,482
-3.7%
0.01%
-7.1%
Q4 2020$124,0000.0%1,5390.0%0.01%
-6.7%
Q3 2020$124,000
-6.1%
1,539
+0.1%
0.02%0.0%
Q2 2020$132,000
+10.9%
1,538
+5.1%
0.02%
-6.2%
Q1 2020$119,000
-2.5%
1,4640.0%0.02%
+6.7%
Q4 2019$122,000
-4.7%
1,464
+0.1%
0.02%
-11.8%
Q3 2019$128,000
+6.7%
1,4630.0%0.02%
+6.2%
Q2 2019$120,000
+1.7%
1,463
-5.8%
0.02%0.0%
Q1 2019$118,000
+4.4%
1,553
-3.0%
0.02%0.0%
Q4 2018$113,000
-0.9%
1,601
+0.2%
0.02%
-20.0%
Q3 2018$114,000
-3.4%
1,598
+0.3%
0.02%
+17.6%
Q2 2018$118,000
+10.3%
1,594
+0.3%
0.02%
+6.2%
Q1 2018$107,000
-4.5%
1,5900.0%0.02%
-5.9%
Q4 2017$112,000
-19.4%
1,590
-29.6%
0.02%
-26.1%
Q3 2017$139,000
+40.4%
2,257
+41.9%
0.02%
+27.8%
Q2 2017$99,000
+16.5%
1,590
-0.1%
0.02%
+12.5%
Q1 2017$85,000
+21.4%
1,591
+2.0%
0.02%
+14.3%
Q4 2016$70,000
+3400.0%
1,560
+5100.0%
0.01%
+1300.0%
Q2 2013$2,000300.00%
Other shareholders
BAXTER INTL INC shareholders Q2 2018
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders